Shanghai Pharmaceuticals Holding Co., Ltd Share Price Other OTC
Equities
SHPMY
US81943R1005
Pharmaceuticals
Sales 2024 * | 288B 39.62B 3,139B | Sales 2025 * | 317B 43.68B 3,460B | Capitalization | 62.6B 8.61B 682B |
---|---|---|---|---|---|
Net income 2024 * | 4.97B 684M 54.15B | Net income 2025 * | 5.6B 771M 61.04B | EV / Sales 2024 * | 0.28 x |
Net Debt 2024 * | 18.42B 2.53B 201B | Net Debt 2025 * | 19.41B 2.67B 212B | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
14
x | P/E ratio 2025 * |
12.4
x | Employees | - |
Yield 2024 * |
2.81% | Yield 2025 * |
3.18% | Free-Float | 38.5% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Zhong Li
PSD | President | 54 | 26/06/19 |
Bo Shen
PSD | President | 51 | 04/06/13 |
Ye Lu
IRC | Investor Relations Contact | 35 | 31/12/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Shen
PSD | President | 51 | 04/06/13 |
Yong Zhong Li
PSD | President | 54 | 26/06/19 |
Manson Fok
BRD | Director/Board Member | 67 | 26/06/19 |
1st Jan change | Capi. | |
---|---|---|
+29.05% | 78.4B | |
+0.56% | 25.12B | |
+2.20% | 8.55B | |
-28.87% | 6.91B | |
+16.06% | 5.34B | |
+1.58% | 4.17B | |
-8.90% | 3.82B | |
-7.62% | 3.37B | |
+9.36% | 3.26B |